Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

COVID-19

 

HBI 2020: Care homes may never return to pre-COVID occupancy

The COVID-19 pandemic is driving regulatory changes in the care home sector across western Europe, said speakers on the 'Elderly Care: How big is the opportunity?' panel at HBI 2020. One said: "Do not assume you will ever see a return to pre-COVID levels of occupancy."

Diagnostics: A new global consumer market?

Here we explore new markets for diagnostics, focusing particularly on B2C consumer markets and genetics. Panelists include: Wolf Kupatt, CEO, Amedes   Recently Amedes has developed a battery of B2C tests around areas such as the gut biome and is conducting genetic tests for consumers in Africa and Asia. What has been the feedback and what is […]

Investing in Emerging Markets

Often dependent on out of pocket payments with close to zero government support, Covid has had a huge impact on health care in Emerging Markets. So is the sector down and out or set to rebound? Charles Dalton, Senior Health Specialist, IFC  Amit Varma, Managing Partner, Quadria Capital Vishal Bali, Executive Chairman, Asia Healthcare Holdings […]

AI, Big Data: II

This session looks at how AI and big data are changing how health care is delivered, whether in diagnosis, patient journey management or the delivery of care. Enabling Precision Health in Oncology – a post-Covid slant Dr Ben Newton PhD – General Manager, Oncology, GE Healthcare Victor Savevski, Chief Innovation Officer, Humanitas Dr Angela Spatharou, […]

Where we are now

How do governments see health care in the wake of Covid? What strategies will they pursue and how does it change the relationship with the for-profit sector?  These are the questions we answer in this 90-minute session. 8.00-8.15  Perspectives from a government trailbazer Austria is an early adopter of electronic patient records and has seen […]

The impact of Covid on for-profit health care

How has Covid affected the different sub-sectors which make up health care and what has been the impact country-by-country and region-by-region? Some such as laboratory services have actually seen growth accelerate thanks to Covid. Others such as dentistry or imaging have been hard hit. At a country level, Germany and Switzerland have seen massive support […]

Rethinking Large Hospital Business Models

Traditional business models are being challenged by large hospital groups – public and private. Increasingly, they are taking ownership of wider activities in areas such as prevention and chronic disease management. They are also expanding their reach into the deployment of AI, digital health and wider medical research activities. This session looks at the strategies […]

Regulatory and Political Risks Post-Covid

This remains the number one issue for investors and operators in most counties, second only to “how do I get staff?” as something liable to keep CEOs awake at night. Here we look in detail at what risks there are in different countries and sectors. what, if anything, can the sector do to allay them? […]

M&A: 2020 and what happens next?

How is Covid affecting valuations for health care service companies in Europe and Emerging Markets. In a detailed data-driven presentation Hedley looks at its impact sector-by-sector. Despite Covid, will cheap money and renewed investor appetite push multiples higher? Followed by a live Q&A session Hedley Goldberg, Managing Director, Rothschild & Co

Find Us